basic FUNCTION
| actin-dependent regulator of chromatin structure |
|
playing an essential role for function of BAF chromatin remodelling complexes in heart development |
|
required for Notch-dependent transcriptional activation and functions to stabilize interactions between activated Notch and its DNA-binding partner |
|
playing a critical role in Notch-dependent transcription and Left-Right asymmetry |
|
is a component of the neural progenitor-specific BAF complex in developing retina |
|
is a necessary co-regulator of TGFB1 mediated induction of Smooth muscle cells (SMCs) genes |
|
is important for TGFB1-mediated commitment of primitive stem cells (rMAPCs) to SMCs |
|
is a specific chromatin remodeling component for lipogenic gene transcription in liver |
|
promotes lipogenesis and increases triglyceride levels, demonstrating its role in metabolic adaption to activate the lipogenic program in response to feeding and insulin |
|
transcriptional cofactor enriched in fast-twitch muscle, promoting a switch from oxidative to glycolytic myofiber type through DEPTOR-mediated AKT1 activation |
|
required for maintaining glycolytic capacity in adult skeletal muscle |
|
SMARCD3-SIX4 transcriptional complex inducing DEPTOR and mediating activation of AKT1 and glycolytic metabolism by SMARCD3 in a cell-autonomous manner |
|
epigenetically regulates EMT by activating WNT signaling pathways |
|
its expression and expression of DEPTOR was downregulated in skeletal muscle in obesity, accompanied by extracellular signal-related kinase (ERK) activation |
|
functional redundancy between SMARCD1 and SMARCD3 in maintaining oxidative and glycolytic metabolism in skeletal myofibers and exercise endurance |
|
SMARCD1, D2, D3 proteins are involved in the regulation of numerous hormone-dependent AR-driven genes, and play an important, yet paradoxical, role in prostate carcinogenesis |
|
SMARCD3 acts with FOXA1 to control lipid and fatty acid metabolism, programs associated with therapy resistance and poor prognosis in cancer |
|
SMARCD3 is an epigenetic modulator responsible for establishing the metabolic landscape in aggressive pancreatic cancer cells and a potential target for new therapies |